Effects of febuxostat on cardiorenal function in patients with heart failure and hyperuricemia
Phase 4
- Conditions
- Chronic heart failure
- Registration Number
- JPRN-UMIN000010270
- Lead Sponsor
- Sakakibara Heart Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication for febuxostat Already receiving medications for hyperuricemia Severe liver dysfunction eGFR<30ml/min/1.73m2 Malignant neoplasm Does not provide IC Essential to give medication for hyperuricemia Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of eGFR
- Secondary Outcome Measures
Name Time Method Cardiac function Anemia Inflammatory marker Cardiac event